Offer - Urjas Oil for just ₹ 1 X
Sybil 375 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Bacterial Infections. Sybil 375 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Sybil 375 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Sybil 375 Tablet have been listed ahead. These side effects of Sybil 375 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Sybil 375 Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Sybil 375 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Sybil 375 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Sybil 375 Tablet in conditions like Drug Allergy, Jaundice. Some other conditions that can be affected by Sybil 375 Tablet are listed in the contraindications section below.
Besides this, Sybil 375 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Sybil 375 Tablet is safe while driving, and is addiction.
Sybil 375 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Sybil 375 Tablet safe for pregnant women?
Sybil may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Sybil again without your doctor's advice.
Is the use of Sybil 375 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Sybil. If you see any side effects, stop taking Sybil immediately and talk to your doctor. Take Sybil again, only after your doctor's advice.
What is the effect of Sybil 375 Tablet on the Kidneys?
Sybil has very mild side effects on the kidneys.
What is the effect of Sybil 375 Tablet on the Liver?
Very few cases of side effects of Sybil on the liver have been reported.
What is the effect of Sybil 375 Tablet on the Heart?
Sybil is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Sybil 375 Tablet unless your doctor advises you to do so -
Is this Sybil 375 Tablet habit forming or addictive?
No, there is no any evidence that Sybil 375 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Sybil 375 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Sybil 375 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Sybil 375 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Sybil 375 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Sybil 375 Tablet together with food.
Interaction between Alcohol and Sybil 375 Tablet
Due to lack of research, there is no information about the side effects of taking Sybil 375 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725